| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b73bb5b611ad02b686a7967bc6ca3412 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
1998-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_473ea51a0f83f731a30bf34090120c5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f4a9eb94662400fc1680184d76e4d95 |
| publicationDate |
2000-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-20002158-A3 |
| titleOfInvention |
Imidazonaphthyridines and their use in the induction of cytokine biosynthesis |
| abstract |
Imidazonaphthyridine Compounds of Formula I anthe tetrahydroimidazonaphthyridine compounds of the formulanII indicate cytokine biosynthesis such as interferon and factorntumor necrosis. The compounds exhibit antiviral ananticancer activity. Methods are also describednpreparing the compounds of the invention and their intermediates. Rj anR 2 and A are as described herein. |
| priorityDate |
1998-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |